![Ehong Gu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ehong Gu
Direttore Finanziario/CFO presso
LIANMEDICAL
Patrimonio netto: - $ in data 31/08/2026
Profilo
Ehong Gu is currently the Chief Financial & Accounting Officer at LianBio.
Previously, she worked as the Assistant Vice President-Finance at CStone Pharmaceuticals Co. Ltd. from 2019 to 2021.
She holds an MBA from Rotman School of Management and an undergraduate degree from Shanghai University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
LIANBIO -.--% | 19/12/2023 | 0 ( -.--% ) | - $ | 31/08/2026 |
Posizioni attive di Ehong Gu
| Società | Posizione | Inizio |
|---|---|---|
| LIANMEDICAL | Direttore Finanziario/CFO | 19/12/2023 |
Precedenti posizioni note di Ehong Gu
| Società | Posizione | Fine |
|---|---|---|
| CSTONE PHARMACEUTICALS | Corporate Officer/Principal | 01/01/2021 |
Formazione di Ehong Gu
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
29
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Rotman School of Management
 Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai University
 Shanghai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CStone Pharmaceuticals Co. Ltd.
 CStone Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatments for oncology, cardiovascular diseases, rheumatoid arthritis, hematology and autoimmune diseases | Health Technology |
LianBio
 LianBio BiotechnologyHealth Technology Operates as a biotechnology company focused on bringing paradigm-shifting medicines to patients | Health Technology |
